Vacant Cobertura
Dates and figures
- From 2019 to 2020, global coverage covers 86% to 83%.
- It is estimated that 23 million minor minorities have not received basic vacancies, which is the highest figure since 2009.
- In 2020, the number of nines that no recipient will receive increased by 3.4 million.
- It was only this year that the introduction of 19 vacancies was recorded, less than the number of years since the last two decades.
- Compared to the previous year, 1.6 million more patients did not receive the full dose of the vaccine against human papillomavirus (VPH).
General information
Although the immunization is one of the most effective public health interventions, the evacuation cover has been established for the last decade. The COVID-19 pandemic and the interruptions associated with it have put a lot of pressure on health systems: 23 million of them were evacuated in 2020, up from 3.7 million more than in 2019 and the highest number since 2009 .
During 2020, three doses of the vaccine will be administered against diphtheria, tetanus and ferrous toxins (DTP3) to 83% of all lactates worldwide (113 million), to protect against these infectious diseases that can provoke transplants and grave disabilities, and including death.
It is only this year that the introduction of 19 vacancies is recorded (excluding the introduction of vacancies against COVID-19), less than the number of years of the last decades. It is likely that this deceleration will continue as the countries are centered on controlling the pandemic of this disease and introducing weapons against it.
World Vacancial Coverage in 2020
Continuation of a summary of global vaccine coverage in 2020.
Haemophilus influenzae of type b (Hib) provokes meningitis and neumonia. In the 2020 finals, the vaccine against the Hib was introduced in 192 Miembros States. It is estimated that the global coverage with three doses of the vaccine against Hib is 70%. There are great disparities between the regions. It is estimated that in the Southeast Asia Region the coverage is 83%, while in the Occidental Pacific Region it is only 25%.
Hepatitis B is a viral infection that affects the liver. In the finals of 2020, the vaccine against hepatitis B was introduced in 190 Miembros States. It is estimated that the global coverage with three doses of the vaccine against hepatitis B is 83%. Además, 113 Estados Miembros han introduced the vaccination of the freshly harvested with a dose in the first 24 hours of life. Global coverage is 42% and is currently 84% in the Occidental Pacific Region, while in the African Region it is estimated that it is only 6%.
Infection with human papillomavirus (VPH) —the most common viral infection of the reproductive system — can provoke cervical cancer in women and other types of cancer and genital warts both in men and women. In the finals of 2020, the vaccine against this virus will be introduced in 111 Miembros States. As many large toadstakes countries have not introduced this vaccine and during this year the coverturia decreases in many others, it is calculated that the global coverage of the final dose against the VPH is 13%. This is a significant proportional reduction of 15% in 2019.
Meningitis It is an infection that causes death and gives birth to one in five people affected by permanent sequelae. Prior to the introduction of MenAfriVac in 2010, a revolutionary vaccine, the meningococcal serogroup was responsible for 80-85% of the epidemics of meningitis in African meningitis. In the 2020 finals, there will be 350 million people in 24 of the 26 countries of the meningitis belt receiving the MenAfriVac vaccine in different campaigns. Once upon a time, MenAfriVac included in its systematic vacancy calendar for 2020.
The sarampi is a very contagious disease caused by a virus that, in general, provokes high fever and eruptions, and can cause cough, encephalitis or death. By the end of 2020, 84% of the children had received a dose of antisarampionic vaccine before completing the two years; for another part 179 States Miembros habían includes a second dose as part of the systematic immunization, and 70% of the nine habían receive dose dose in accordance with the calendar of vacancy of their countries.
Parotiditis is a very contagious viral disease that causes a painful inflammation in the laterals of the caraway, swelling of the eyelids (the parotid glands), fever, headaches and muscle aches. You can remove a viral meningitis. In the final of 2020, the vaccine against this disease will be introduced in 123 Miembros States.
Neumococcal infections are neonatal, meningitis and bacterial fever, in addition to otitis media, sinusitis and bronchitis. By 2020, the antineum vaccine vaccine has been introduced in 151 Miembros States (in three of them, has been introduced in parts of the territory), and the global coverage of the third dose is estimated at 49%.
Poliomyelitis is a highly contagious viral infection that can provoke irreversible paralysis. In 2020, 83% of all lactants will receive three doses of the anti-polio vaccine vaccine. In 2020, the percentage of lactants that received the first dose of the inactivated anti-polio vaccine (IPV) in countries that used the oral anti-polio vaccine (OPV) was estimated at 80%. Poliomyelitis, which is the object of mediation for its global eradication, has been eliminated in all cases in Afghanistan and Pakistan. While not interrupting the transmission of poliovirus in their countries, the same countries will follow the risk of importing the virus, regarding all vulnerable waterways with public health services and fragile evacuation, that commercial vultures in them and elsewhere in the country receipt of travel proceeds from allies.
Rotaviruses are the most common cause of severe diarrheal infections between the small nipples all over the world. In the 2020 finals, the vaccine against rotavirus was introduced in 114 countries; in three of them, only in parts of the territory. The estimated global coverage is 46%.
The rubella is a viral disease that generally lives in the kidneys, if the infection at the beginning of the embarrassment can lead to fetal death or the syndrome of congenital rubella, which can provoke death in the brain, the brain, the ovaries and the oidos. In the 2020 finals, the vaccine against this disease was introduced at the national scale in 173 Member States and the global coverage estimated at 70%.
The tetanus is a disease provoked by a bacterium that grows in oxygen, for example, in hereditary wounds in the umbilical cord it does not have a limp. The spores of C. tetani are present in the ambient medium, independently of the geographical location. The bacteria produce a toxin capable of causing serious complications, including death. The maternal and neonatal tetanus is seen as a public health problem in 12 countries, mainly in Africa and Asia.
Emerald fever is a serious viral hemorrhagic disease transmitted by infected mosquitoes. Until 2019, the vaccine against amarie fever has been introduced in the systematic immunization programs of lactating people of 36 of the 40 countries and territories of Africa and the United States organized by it. In these 40 countries and territories, it is estimated that the coverage is 45%.
Retos principals
In 2020, 17.1 million lactating people will not receive an initial dose of the DTP vaccine, which is due to a lack of access to immunization services and other health services, and another 5.6 million are only partially vaccinated. Of these 23 million more than 60% live in 10 countries, including: Angola, Brazil, Ethiopia, Philippines, India, Indonesia, Mexico, Nigeria, Pakistan and the Democratic Republic of Congo.
The implementation of sub-national level data is fundamental to help the countries prioritize and adapt their evacuation strategies and operational plans to prevent breaches of immunization and make sure that all the evacuated persons can be rescued.
Response from the OMS
The OMS collaborates with the countries and associations to increase global vacancy coverage, in particular through the initiatives adopted by the World Health Assembly in August 2020.
Agenda for Immunization 2030
The Agenda for Immunization, AI2030, establishes an ideal and ambitious strategy of global ambition in the matter of vacancies and immunization for the decade 2021-2030. Created, among other things, miles of landscapes and worldwide organizations. Approve the derivative teachings of the last decade and keep in mind the new and persistent nets that plant infectious diseases (for example, Ebola or COVID-19).
The strategy has been designed to respond to the interests of each country and its objective is to inspire and harmonize the activities of interested parties, communitarian, national, regional and global, to log a world in which all, in all parties, benefit full of vacancies for a good health and well-being. The AI2030 is based on a range of national and regional strategies and mechanisms that guarantee accountability assumptions and yields, and a follow-up and evaluation brand that orients applications in countries.
Global strategy to accelerate the elimination of uterine cancer as well as the problem of public health
In 2020, the World Health Assembly adopted the world strategy to accelerate the elimination of uterine cancer. In the first of the three pillars of the strategy, the introduction of the vaccine against the VPH is required in all countries with a target of 90% coverage. Taking into account that the percentage of introduction of this vaccine in the Miembros States is currently 57% considerable inversions to introduce the vaccine in low and median birth rates in the next three years, as well as in programs for 90% coverage of entanglements as high as high altos, as predicted in the 2030 metas.